Skip to content

Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®

Clinical Priority Program (CPP) Clinical Outcome Measurement of Fracture Treatment:

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04113044
Enrollment
1500
Registered
2019-10-02
Start date
2021-02-01
Completion date
2026-12-31
Last updated
2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankle Fractures, Distal Radius Fracture, Hip Fractures, Humeral Fracture, Proximal, Tibial Fractures

Keywords

PRO, HOOS, KOOS, FAAM, PROMIS, QuickDASH, PSEQ, PAM

Brief summary

Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups). Patients will be followed up according to the standard (routine) for up to 1 year after the treatment. Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.

Detailed description

More in detail this observational study includes the following sub-projects: I) Weight -bearing and Gait Observation for Fully Individualized Treatment and Aftercare Following Surgery and Trauma Objectives: To analyse the association between automated, sensor-based patient activity and loading data, and clinical (Patient Reported Outcomes \[PROs\]) and radiographic outcome during fracture healing. II) Recovery Trajectory using PROMIS®: Defining the Recovery Trajectory using PROMIS® to Optimize Decision-making and Outcomes following Extremity Fractures Objectives: 1. To identify the factors predictive of longer term magnitude of limitations after extremity fractures (using PROMs) 2. To assess minimal clinically important difference (MCID) and substantial clinical benefit (SCB) in PROM scores 3. To define recovery trajectories of PROMs i.e. range, normative limits and score thresholds III) Linking PROMIS®: Linking of PROMIS Measures to Legacy Measures in an Orthopaedic Patient Population Objectives: 1. Administer and collect responses to the PROMIS PF/UE and PAIN INT and the four orthopaedic legacy measures in the same group of orthopaedic trauma patients. 2. Apply the methods of item-response theory (IRT) linking to establish a common standardized metric. 3. Develop equations for conversion of a PROMIS PF/UE and PAIN INT score to each of the specified legacy measures and vice-versa.

Interventions

OTHERAll treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.

Sponsors

AO Innovation Translation Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Age 18 years and older * Diagnosis of one of, isolated injury * Hip fracture * Tibial shaft fracture (with and without associated fibular fracture) * Ankle/pilon fracture * Proximal humerus fracture * Distal radius fracture * English, German, or Spanish speaking * Informed consent obtained, i.e.: * Ability to understand the content of the patient information/ICF * Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP) * Signed and dated EC/IRB approved written informed consent

Exclusion criteria

* More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision * Patients with multiple fractures * Pathological fractures due to cancer * Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment * Pregnancy or women planning to conceive within the study period * Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place * Prisoners * Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study * Patients unable to likely achieve anticipated Follow-up (FU)

Design outcomes

Primary

MeasureTime frameDescription
Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysisfrom the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)* Radiographic measurements o Healing (Radiographic Union Score in Tibia Fractures \[RUST\]/ Radiographic Union Score in Hip Fractures \[RUSH\]) * Patient related outcomes * Patient Reported Outcome Measurement Information System (PROMIS): Physical Function (PF) short form Custom AO14 Pain Interference * Hip Disability and Osteoarthritis Outcome Score (HOOS-12) (assessing short- and long-term symptoms and function in hip injuries; the lower score indicates higher symptoms) * Knee Injury and Osteoarthritis Outcome Score (KOOS-12) (assessing short- and long-term symptoms and function in knee injuries; the lower score indicates higher symptoms) * Loading/Activity pattern analysis: * Number of steps with weight-bearing \>80% body-weight (weight in kg) * pressure distribution \[N/cm2\] * center of pressure \[mm\] * ground reaction forces \[N\] * temporal and spatial parameters (time spent during gait \[min\], stance time \[s\], swing time \[s\], double support time \[s\], cadence \[r/min\], cycle time \[s\])
Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAMfrom the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)PROs that measure physical limitations: * PROMIS PF Short Form Custom AO14 (questions that cover the domain of physical function/mobility from self-care to strenuous activities) * PROMIS Upper Extremity (UE) Short Form Custom AO8 (questions assessing arm and hand specific limitations, e.g. difficulty writing, lifting heavy objects; a higher score indicates a better function) * Disabilities of the Arm, Shoulder, and Hand (QuickDASH) (11 questions assessing outcomes in upper extremity disorders; a higher score indicates a greater disability) * HOOS-12 * KOOS-12 * Foot and Ankle Ability Measure (FAAM) (21 items of activities of daily living subscale) * PROMIS Global Health (10 questions assessing physical health, mental health, and social health; a higher score indicates a better general health)

Secondary

MeasureTime frameDescription
PROMIS Pain Interferencefrom the treatment assessment until 12 months after the treatment (surgical or not-surgical)PROMIS Pain Interference (8 questions) assesses the impact of pain on common activities of daily life including social, cognitive, emotional, physical, and recreational aspects. The higher score represents a higher pain level
PROMIS Depressionfrom the treatment assessment until 12 months after the treatment (surgical or not-surgical)PROMIS Depression assesses negative mood (sadness, guilt), views of self (worthlessness, self-criticism) and diminished positive affect and engagement (loss of interest) within the previous week. The higher score represents higher depression level
PROMIS Anxietyfrom the treatment assessment until 12 months after the treatment (surgical or not-surgical)PROMIS Anxiety assesses levels of anxiety through measuring aspects of fear (e.g. fearfulness, feelings of panic), anxious misery (e.g. worry, dread), hyperarousal (e.g. tension, nervousness, restless) and some somatic symptoms related to arousal (e.g. dizziness). The higher score represent the higher level of anxiety
PROMIS Ability to Participate in Social Roles and Activitiesfrom the treatment assessment until 12 months after the treatment (surgical or not-surgical)PROMIS Ability to Participate in Social Roles and Activities item bank assesses the perceived ability to perform one's usual social roles and activities. The higher score represents better ability for social roles
Pain Self-Efficacy Questionnaire (PSEQ)-2from the treatment assessment until 12 months after the treatment (surgical or not-surgical)PSEQ-2 assesses adaptive coping strategy and the confidence one can achieve one's goals in spite of pain. Items are scored on a 7-point Likert scale and added to form a total score ranging from 0 to 12, with higher scores indicating greater self-efficacy
Patient Activation Measure (PAM)-10from the treatment assessment until 12 months after the treatment (surgical or not-surgical)PAM-10 assesses activation and the personal and psychological competencies. PAM segments individuals into one of four activation levels along an empirically derived 100-point scale. Individuals in the highest activation level are proactive with their health, have developed strong self-management skills, and are resilient in times of stress or change.
Cognitive assessmentPre-treatmentThe MiniCog is a 3-minute instrument assessing cognitive impairment. It consists of two components, a 3-item recall test for memory and a simply scored clock drawing test. A total score ranges from 0 to 5. A score of zero, one or two out of five points in total, indicates a concern in cognitive functioning.
Mobility ScoresPre-treatmentParker Mobility Scale assess the patient's ability to perform indoor walking, outdoor walking, and shopping before the fracture. A score ranges between 0 and 3 (0 = not at all, 1 = with help from another person, 2 = with an aid, and 3 = no difficulty and no aid) for each function, resulting in a total score ranging from 0 (no walking ability at all) to 9 (fully independent).
RUSH scorefrom the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)Radiographic Union Score in Hip Fractures
RUST scorefrom the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)Radiographic Union Score for Tibia
Numeric Rating Scale (NRS) Painfrom the treatment assessment until 12 months after the treatment (surgical or not-surgical)An ordinal scale from 0 to 10 with 0 indicating no pain and 10 indicating extreme pain.

Countries

Austria, Colombia, Germany, Netherlands, United Kingdom, United States

Contacts

PRINCIPAL_INVESTIGATORMarilyn Heng

Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative

PRINCIPAL_INVESTIGATORPrakash Jayakumar

Dell Medical School, University of Texas at Austin

PRINCIPAL_INVESTIGATORTim Pohlemann

Saarland University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026